ETBA連續第三年舉辦瑞士台灣生技領導人論壇，希望持續創造雙方在生物科技方面交流，繼去年在瑞士舉辦的瑞士台灣生技領導人論壇受到廣大迴響。今年因全球疫情影響，本次跨國論壇改採線上進行。瑞士方協會邀請瑞士諾華藥廠、巴塞爾經濟與創新促進局與瑞士生技協會的專家，台灣方面則由生物技術開發中心與台灣生物產業發展協會為代表，一同討論在全球新型冠狀病毒 (COVID-19) 疫情下，生技產業受到的衝擊與未來展望，探討瑞士與台灣之間創造潛在跨國合作機會。

論壇時間：2020/7/16 (星期四) 16:00 - 17:00 台灣時間

論壇語言：英文

講座地點：Zoom 線上論壇 

報名時間：即日起至額滿為止

主辦單位：歐洲台灣生技協會 (ETBA) 

報名連結：https://bit.ly/2020etba
 

Switzerland-Taiwan Biotech Leaders Virtual Forum

Date:

Jul. 16th, 2020

Time:

10:00-11:00  AM (CEST, 歐洲中部夏令時間)
04:00-05:00  PM (Taiwan Time, 臺灣時間)

Venue: 

Zoom Virtual Meeting

Intro:

Covid19 pandemic has created an unprecedented impact on the biotech industry around the globe. At the same time, such a crisis also provides opportunities to unite the industry and sparks extraordinary cooperation for finding therapeutics.

In this event, experts from Switzerland and Taiwan will sit together remotely and share their views on:

1. The most critical impact of covid19 pandemic on biotech industries in Switzerland and Taiwan
2. Innovative measures that the industry has taken during the crisis and the new normality
3. Opportunities to collaborate and form a more resilient biotech alliance in the future  

Invited Speakers

• Michael Altorfer
  CEO, Swiss Biotech Association
• Johnsee Lee 李鍾熙
  Chairman, Taiwan Bio Industry Organization
• John Tsai
  Head of Global Drug Development and Chief Medical Officer, Novartis
• Shiing-Jer Twu 涂醒哲
  Chairman, Development Center for Biotechnology

Moderation    

Thomas Brenzikofer
Co-Founder and Manager, DayOne, Basel Area Business & Innovation

   Background image designed by kjpargeter / Freepik